MARIAH COX: Open Payments
NPI 1760941223 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,740 in 115 payments from 19 companies in 2025. Trend: 2023 $2,837 · 2024 $2,287 · 2025 $5,740
Food & beverage: $2,904Travel & lodging: $2,772Education: $64
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 21 | $2,706 |
| Boston Scientific Corporation | 8 | $1,343 |
| ABIOMED | 16 | $430 |
| E.R. Squibb & Sons, L.L.C. | 20 | $317 |
| Actelion Pharmaceuticals US, Inc. | 5 | $131 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $98 |
| Amgen Inc. | 5 | $84 |
| PFIZER INC. | 5 | $79 |
| Bard Peripheral Vascular, Inc. | 3 | $76 |
Products named: CARDIOMEMS, WATCHMAN, CAMZYOS, WATCHMAN Access System, ELIQUIS, LEQVIO, Kerendia, REPATHA.
Industry payments across MS — which companies pay providers there.
